Monitoring CD27Â + memory B-cells in neuromyelitis optica spectrum disorders patients treated with rituximab: Results from a bicentric study

In our study, mBc-based administration of RTX allowed personalizing treatment administration and in several cases to lower the cumulative dose without loss of efficacy.